NCT01894230 - Genetically Guided Statin Therapy | Biotech Hunter

Enrollment

167

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

HypercholesterolemiaHydroxy-methylglutaryl-coenzyme A (HMG Co-A) Reductase Inhibitors Adverse Reaction

Interventions

GENETIC

SLCO1B1*5 allele testing, results reported at randomization

Genetic testing for SLCO1B1\*5 allele and reporting of results to patient and provider at randomization

GENETIC

SLCO1B1*5 allele testing, results reported at end of study

Genetic testing for SLCO1B1\*5 allele and reporting of results to patient and provider at end of study

GENETIC

Genetic testing for SLCO1B1*5 allele

Blood test for SLCO1B1\*5 allele

Trial Locations (2)

Duke University, Durham

David Grant US Air Force Medical Center, Travis Air Force Base